Menu

Chromosomal Instability Drives Cancer Metastasis

In the presence of cytosolic DNA, cancer cells activate antiviral pathways that disguise them as immune cells.

Apr 1, 2018
Jim Daley

BREAKING FREE: When a chromosomally unstable cell divides, its chromosomes can become disordered during anaphase (1). Errors in segregation can allow chromosomes to leak into the cytosol, where they form “micronuclei” (2), which trigger an inflammatory response in the daughter cell (3). This response can lead to metastasis.
See full infographic: WEB
© IKUMI KAYAMA/STUDIO KAYAMA

 

EDITOR'S CHOICE IN ONCOLOGY

The paper
S.F. Bakhoum et al., “Chromosomal instability drives metastasis through a cytosolic DNA response,” Nature, 553:467-72, 2018.

Aneuploidy—the presence of abnormal numbers of chromosomes in a cell—is associated with cancer metastasis, but scientists have struggled to connect the mechanistic dots underlying the phenomenon. To explore the association, a team of researchers led by Lewis Cantley, a cancer biologist at Weill Cornell Medicine, and Sam Bakhoum, a radiation oncologist at Memorial Sloan Kettering Cancer Center, recently injected chromosomally unstable breast and lung cancer cells into mice, and saw that the cells were more likely to metastasize than cells in which chromosomal instability was suppressed. To the researchers’ surprise, they also observed a heightened inflammatory response in the chromosomally unstable cells even before they were injected into the mice.

These findings led the scientists to examine whether the cells had an innate immune response to cytosolic DNA. Ongoing segregation errors in cancer cells can allow chromosomes to leak from the nucleus into the cytosol, forming “micronuclei” that expose naked DNA to the cytosol when they rupture. The research team first compared genomic integrity—a proxy for chromosomal stability—of primary tumors and metastases in data from a 2015 study, and found more instability in the metastases. They then transplanted metastatic cancer cells with chromosomal instability into mice, and found that an antiviral immune response called the cGAS-STING pathway was chronically switched on in the cells.

Normally, epithelial cells immediately die when cGAS-STING signals are expressed. But Bakhoum says metastatic cancer cells may adapt not just to survive the activation, but to use it to their advantage. That’s because the same cytosolic DNA–activated pathway mediates the migration of macrophages and other immune cells to an area apparently under viral attack. This raises the possibility that cancer cells are “reacting to cytosolic DNA like immune cells rather than like normal epithelial cells,” he says, enabling them to metastasize to distant sites.

“The analogy I like to use is [a] wolf in sheep’s clothing,” adds Cantley. Testing for cytosolic DNA in a primary tumor could “be predictive of who’s going to metastasize,” he says.

Virginia Tech cell biologist Daniela Cimini, who has collaborated with Bakhoum in the past but was not involved in this study, says it raises a red flag for one therapeutic avenue. “A lot of labs right now are focusing on possibly increasing chromosomal instability as a therapeutic strategy for cancer,” because such instability appears to disrupt tumor formation and early progression, Cimini tells The Scientist. “If [chromosomal instability] promotes metastasis, now we’re in trouble.”

Cantley says the study may also have implications for the use of current treatments, such as radiation and chemotherapy, that also induce chromosomal instability. “We . . . have to be cognizant of the possibility that many of our therapies for primary tumors are probably actually increasing the probability of metastasis.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing